KCNIP3 and depressive symptom measurement: Therefore, decreased dopaminergic and serotonergic neurotransmission might contribute to the enhanced pain-induced aversion, anxiety- and depression-like behaviors in Kcnip3-/- rats under both basal and inflammatory pain conditions.